4Tanabe K,Suzuki T,Tokumoto N,et al.Combination therapy with do-cetaxel and S-1 as a first-line treatment in patients with advanced or re-current gastric cancer:a retrospective analysis[J].World J Surg Oncol,2010;8(5):40.
5Ajani JA,Rodriquez W,Bodoky G,et al.Multicenter phaseⅢcompari-son of cisplatin/S-1 with cisplatin/infusional fluorouracil in advancedgastric or gastroesophageal adenocarcinoma study:the FLAGS trial[J].JClin Oncol,2010;28(9):1547-53.
6[1]Sasaki T,Maeda Y,Kobayashi T,et al.Standard chemotherapy for gastrointestinal malignancies based on evidence.Jap J Cancer Chemother,2000,27 (20):166
7[4]Jin M,Shen L,Hu B,et al.Mature data on capecitabine (X) + fractionated cisplatin (P) as first-line therapy in patients (pts) with advanced gastric carcinoma (AGC).Proc Am Soc Clin Oncol,2006,24:196S
8[5]Kang Y,Kang WK,Shin DB,et al.Randomized phase Ⅲtrial of capecitabine/cisplatin (XP) vs continuous infusion of 5 -FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC):Efficacy and safety results.Proc Am Soc Clin Oncol,2006,24:183S
9[6]Shitara K,Sakata Y,Kudou T,et al.Gastric Cancer:S -1 monotherapy and its progress.Jpn J Cancer Chemother,2006,33 (Suppl I):43
10[7]Ajani JA,Fodor MB,Tjulandin SA,et al.Phase Ⅱ multiinstitutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated,advanced gastric or gastroesophageal adenocarcinoma.J Clin Oncol,2005,23 (24):5660
